(19)
(11) EP 2 641 556 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.03.2020 Bulletin 2020/10

(45) Mention of the grant of the patent:
08.01.2020 Bulletin 2020/02

(21) Application number: 13160122.1

(22) Date of filing: 20.03.2013
(51) International Patent Classification (IPC): 
A61B 18/14(2006.01)
A61B 5/042(2006.01)
A61N 1/18(2006.01)
A61B 18/00(2006.01)
 A61B 5/046(2006.01)
A61B 18/24(2006.01)
A61B 17/00(2006.01)

(54)

Flower catheter for mapping and ablating veinous and other tubular locations

Flowerkatheter für Mapping und Ablation an venösen und anderen röhrenförmigen Positionen

Cathéter en forme de fleur pour cartographie et ablation veineuse et autres emplacements tubulaires

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 21.03.2012 US 201213425895

(43) Date of publication of application:
25.09.2013 Bulletin 2013/39

(60) Divisional application:
19218563.5

(73) Proprietor: Biosense Webster (Israel) Ltd.
Yokneam, 2066717 (IL)

(72) Inventor:
  • Fang, Itzhak
    Irvine, CA California 92614 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
EP-A1- 1 417 936
EP-A2- 1 992 300
US-A- 4 172 451
 EP-A2- 1 323 375
WO-A1-99/52423
US-A- 5 551 426
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).